ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC
Published: 20/10/21, 12:42pm (AEST)•5 pages